Stocks Health care CBLL
NASDAQ · Health careCeribell, Inc. (CBLL)
Ceribell, Inc. brought in $108.7M of revenue over the twelve months to September 30, 2026, up 31.3% from a year earlier. It posted a net loss of $73.9M. In fiscal 2025 capital spending exceeded operating cash flow by $41.6M. At September 30, 2026 it held $42M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 3, 2026.
Key facts about Ceribell, Inc.
- Net worth
- Ceribell, Inc. has a market value (market cap) of $1.1B at the latest share price, and shareholders' equity of $117.5M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $89.1M (+36.1% year on year), with a net loss of $53.4M. Over the 12 months to September 30, 2026: revenue $108.7M, net loss $73.9M.
- Cash flow
- In fiscal 2025 operations used $40.8M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 3, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Ceribell, Inc.'s next report is expected around February 23, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Ceribell, Inc. does
Ceribell, Inc. is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NASDAQ under the ticker CBLL.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $89.1M | -$53.4M | -$1.46 | -$41.6M |
| 2024 | $65.4M | -$40.5M | -$3.39 | -$36.4M |
| 2024 | $45.2M | -$29.5M | -$5.56 | -$30.1M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where CBLL ranks in Health care
Latest SEC filings
What Ceribell, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 3, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 30% to $29.3M versus the same quarter last year; diluted EPS -$0.55 versus -$0.37.
- November 3, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 10, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 33% to $28.1M versus the same quarter last year; diluted EPS -$0.51 versus -$0.38.
- August 10, 2026
- August 6, 2026Passive stake changed SCHEDULE 13G/A
- July 30, 2026
- July 27, 2026Passive stake (5% or more) SCHEDULE 13G
- June 2, 2026
- May 14, 2026Passive stake changed SCHEDULE 13G/A
Insider trades
What the people running Ceribell, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $4.4M worth of shares in the last 90 days and bought none on the open market. Most of the selling (87%) was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| November 2, 2026 | Woo RaymondChief Technology Officer | Exercised options | 4,864 | $17.8K |
| November 2, 2026 | Woo RaymondChief Technology Officer | Exercised options | 23 | $108.1 |
| November 2, 2026 | Woo RaymondChief Technology Officer | Soldpre-planned (10b5-1) | 4,887 | $131.8K |
| October 1, 2026 | Woo RaymondChief Technology Officer | Exercised options | 4,864 | $17.8K |
| October 1, 2026 | Woo RaymondChief Technology Officer | Exercised options | 23 | $108.1 |
| October 1, 2026 | Woo RaymondChief Technology Officer | Soldpre-planned (10b5-1) | 4,887 | $119.1K |
| September 15, 2026 | Blumberg ScottChief Financial Officer | Exercised options | 846 | $8K |
| September 15, 2026 | Blumberg ScottChief Financial Officer | Soldpre-planned (10b5-1) | 846 | $21.2K |
Who owns CBLL
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Fmr LLC13G, passive with 1 related filers | 15% | August 6, 2026 |
| Tpg GP A, LLC13G, passive with 2 related filers | 7.8% | August 14, 2026 |
| Longitude Capital Partners IV, LLC13D, may seek influence with 3 related filers | 7% | October 22, 2024 |
| Red Tree GP, LLC13G, passive with 3 related filers | 6.2% | February 14, 2025 |
| Josef Parvizi13G, passive | 5.8% | February 12, 2025 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 123 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Fmr LLC | 5,691,393 | +840,962 |
| Tpg GP A, LLC | 3,761,154 | -206,268 |
| Red Tree Management, LLC | 2,205,661 | 0 |
| BlackRock, Inc. | 1,936,093 | +122,938 |
| Vanguard Capital Management LLC | 1,130,346 | -6,786 |
| KCM Capital Inc | 1,125,000 | -275,000 |
| Federated Hermes, Inc. | 939,600 | +136 |
| Franklin Resources Inc | 918,349 | +108,835 |
| Adage Capital Partners GP, L.L.C. | 900,000 | +143,249 |
| Bank of New York Mellon Corp | 896,488 | -264,279 |
| TimesSquare Capital Management, LLC | 780,552 | +64,084 |
| Millennium Management LLC | 727,225 | +175,204 |
| Geode Capital Management, LLC | 668,134 | +56,157 |
| Royce & Associates LP | 605,010 | +89,290 |
| State Street Corp | 547,035 | +21,603 |
| Silvercrest Asset Management Group LLC | 468,806 | -20,936 |
| Massachusetts Financial Services Co | 389,675 | -118,815 |
| Redmile Group, LLC | 386,786 | 0 |
| Jpmorgan Chase & Co | 345,152 | +57,946 |
| Yu Fan | 342,398 | -207,050 |
Insiders
14 insiders reported holding 5,883,600 shares in total, about $162.4M at the last price.
| Holder | Shares |
|---|---|
| Tpg Gp A, LLCFormer 10% Owner | 3,765,0543,765,054 held indirectly |
| Chao XingjuanPresident and CEO, Director | 746,345 |
| Parvizi JosefDirector | 745,936722,652 held indirectly |
| Woo RaymondChief Technology Officer | 203,118 |
| Blumberg ScottChief Financial Officer | 146,600 |
| Manni Joseph S.Chief Revenue Officer | 55,956 |
| Taylor Joseph MichaelDirector | 48,478 |
| Foehr DavidSenior VP, Finance and PAO | 34,144 |
| Rogers Erica J.Director | 33,054 |
| Robertson Rebecca BDirector | 26,587 |
Questions about CBLL
What does Ceribell, Inc. do?
Ceribell, Inc. is a company in the Health care sector, listed on NASDAQ as CBLL. Its shares trade on NASDAQ under the ticker CBLL.
What is Ceribell, Inc.'s net worth?
Ceribell, Inc. has a market value (market cap) of $1.1B at the latest share price, and shareholders' equity of $117.5M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Ceribell, Inc. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $73.9M on revenue of $108.7M.
How much revenue does Ceribell, Inc. make?
Over the twelve months to September 30, 2026 Ceribell, Inc. reported revenue of $108.7M. That is 31.3% more than a year earlier.
When did Ceribell, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 3, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the planned insider sale from November 9, 2026.
When is Ceribell, Inc.'s next earnings report?
Ceribell, Inc.'s next report is expected around February 23, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare CBLL with
Follow CBLL
Get an email when Ceribell, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Ceribell, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.